Cargando…
Editorial: Translation of genetically engineered T cells in cancer immunotherapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513460/ https://www.ncbi.nlm.nih.gov/pubmed/37744369 http://dx.doi.org/10.3389/fimmu.2023.1278677 |
| _version_ | 1785108575597625344 |
|---|---|
| author | Voss, Ralf-Holger Echchannaoui, Hakim Huang, He Xue, Shao-An |
| author_facet | Voss, Ralf-Holger Echchannaoui, Hakim Huang, He Xue, Shao-An |
| author_sort | Voss, Ralf-Holger |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10513460 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105134602023-09-22 Editorial: Translation of genetically engineered T cells in cancer immunotherapy Voss, Ralf-Holger Echchannaoui, Hakim Huang, He Xue, Shao-An Front Immunol Immunology Frontiers Media S.A. 2023-09-07 /pmc/articles/PMC10513460/ /pubmed/37744369 http://dx.doi.org/10.3389/fimmu.2023.1278677 Text en Copyright © 2023 Voss, Echchannaoui, Huang and Xue https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Voss, Ralf-Holger Echchannaoui, Hakim Huang, He Xue, Shao-An Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title | Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title_full | Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title_fullStr | Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title_full_unstemmed | Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title_short | Editorial: Translation of genetically engineered T cells in cancer immunotherapy |
| title_sort | editorial: translation of genetically engineered t cells in cancer immunotherapy |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513460/ https://www.ncbi.nlm.nih.gov/pubmed/37744369 http://dx.doi.org/10.3389/fimmu.2023.1278677 |
| work_keys_str_mv | AT vossralfholger editorialtranslationofgeneticallyengineeredtcellsincancerimmunotherapy AT echchannaouihakim editorialtranslationofgeneticallyengineeredtcellsincancerimmunotherapy AT huanghe editorialtranslationofgeneticallyengineeredtcellsincancerimmunotherapy AT xueshaoan editorialtranslationofgeneticallyengineeredtcellsincancerimmunotherapy |